ZANELLATO, Ilaria
 Distribuzione geografica
Continente #
EU - Europa 1.049
NA - Nord America 1.022
AS - Asia 314
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 2.394
Nazione #
US - Stati Uniti d'America 997
IE - Irlanda 311
DE - Germania 211
SE - Svezia 174
IT - Italia 139
UA - Ucraina 110
CN - Cina 80
SG - Singapore 73
HK - Hong Kong 70
FI - Finlandia 58
IN - India 58
CA - Canada 25
IR - Iran 15
GB - Regno Unito 13
BE - Belgio 10
VN - Vietnam 7
RO - Romania 5
TR - Turchia 5
AL - Albania 4
BR - Brasile 4
FR - Francia 4
LT - Lituania 3
AT - Austria 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
ID - Indonesia 2
JP - Giappone 2
MY - Malesia 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
PL - Polonia 1
Totale 2.394
Città #
Dublin 311
Jacksonville 211
Dearborn 107
Chandler 93
Hong Kong 70
Piemonte 62
Wilmington 57
Singapore 50
Ann Arbor 48
Lawrence 34
Princeton 34
Beijing 32
San Mateo 29
Grafing 26
Bremen 25
Munich 22
Toronto 21
Ashburn 19
Andover 17
Leawood 13
Brussels 10
Zanjan 8
Hefei 7
Monmouth Junction 7
Woodbridge 7
Dong Ket 6
Helsinki 6
Kunming 6
Nanjing 6
Udine 6
Boardman 5
Kocaeli 5
Los Angeles 5
Ardabil 4
Cave Creek 4
Fairfield 4
Gunzenhausen 4
Hebei 4
Milan 4
Sacramento 4
Santa Clara 4
Wuhan 4
Augusta 3
Berlin 3
Dallas 3
Houston 3
Jinan 3
Norwalk 3
Shenyang 3
Trieste 3
Winnipeg 3
Ahmedabad 2
Cambridge 2
Celle 2
Chengdu 2
Cuenca 2
Fuzhou 2
Henderson 2
Innsbruck 2
Lerici 2
London 2
Monzuno 2
New York 2
Novara 2
Pavia 2
Pelotas 2
Seattle 2
Sepang 2
Sumedang 2
Tirana 2
Torino 2
Ueda 2
Varanasi 2
Zagreb 2
Alba 1
Asti 1
Bellinzago Novarese 1
Brno 1
Busalla 1
Changchun 1
Changsha 1
Chaoyang 1
Chapel Hill 1
Chongqing 1
Espoo 1
Genzano Di Roma 1
Grafenhausen 1
Hamilton 1
Harbin 1
La Canada Flintridge 1
Lomazzo 1
Madrid 1
Ningbo 1
Novi Ligure 1
Palo Del Colle 1
Paris 1
Quzhou 1
Redmond 1
Redwood City 1
Rio De Janeiro 1
Totale 1.500
Nome #
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 93
Different strategies to exploit Pt(IV) complexes as pro-drugs 90
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 88
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 82
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 80
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 76
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 76
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 74
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 74
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 73
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 73
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 69
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 69
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 65
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 65
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 65
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 65
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 64
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 64
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 63
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 63
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 62
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 61
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 61
Pt(IV) complexes as anticancer prodrugs 61
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells 61
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 60
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 60
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 58
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 58
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 58
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 55
Platinum-bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis 55
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 55
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 54
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 53
Adenomatoid hyperplasia of the upper lip 33
Effects of Ferrocene and Ferrocenium on MCF-7 Breast Cancer Cells and Interconnection with Regulated Cell Death Pathways 4
Totale 2.440
Categoria #
all - tutte 12.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020353 0 0 0 0 0 71 97 23 47 72 39 4
2020/2021310 35 6 38 4 37 14 37 1 52 34 39 13
2021/2022324 35 2 28 29 24 0 43 3 12 5 72 71
2022/2023716 36 29 48 14 58 82 23 31 340 9 37 9
2023/2024238 18 25 25 5 38 2 45 7 3 3 45 22
2024/2025118 5 17 32 10 51 3 0 0 0 0 0 0
Totale 2.440